Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country

Viruses. 2021 Apr 30;13(5):804. doi: 10.3390/v13050804.

Abstract

It is unclear whether universal PCR screening for SARS-CoV-2 in asymptomatic individuals prior to admission is useful. From April to December 2020, the positive rate of universal pre-admission screening was 0.005% (4/76,521) in a tertiary care hospital in Korea. The positive rates were not different between the periods (period 1 (daily new patients of <1 per million inhabitants) vs. period 2 (1-8.3 per million inhabitants) vs. period 3 (10.3 to 20 per million inhabitants); P = 0.45). Universal pre-admission screening for SARS-CoV-2 had a lower positive rate than that of symptom-based screening (0.005% vs. 0.049% (53/109,257), p < 0.001). In addition, seven patients with negative pre-admission test results had subsequent positive PCR during hospitalization, and four patients had secondary transmission. Universal pre-admission PCR screening may not be practical in settings of low prevalence of COVID-19, and negative PCR results at admission should not serve as a basis for underestimating the risk of nosocomial spread from asymptomatic patients.

Keywords: COVID-19; SARS-CoV-2; universal screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asymptomatic Diseases / epidemiology*
  • COVID-19 Nucleic Acid Testing / methods*
  • COVID-19* / diagnosis
  • COVID-19* / epidemiology
  • Carrier State* / diagnosis
  • Carrier State* / epidemiology
  • Humans
  • Nasopharynx / virology*
  • Prevalence
  • Republic of Korea / epidemiology
  • SARS-CoV-2 / isolation & purification*
  • Tertiary Care Centers